144 related articles for article (PubMed ID: 23738729)
1. Effects of herbal supplements on the bioactivation of chemotherapeutic agents.
Gorman GS; Coward L; Darby A; Rasberry B
J Pharm Pharmacol; 2013 Jul; 65(7):1014-25. PubMed ID: 23738729
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibitory effects of herbal supplements on tamoxifen and irinotecan metabolism.
Grappe F; Nance G; Coward L; Gorman G
Drug Metabol Drug Interact; 2014; 29(4):269-79. PubMed ID: 25153228
[TBL] [Abstract][Full Text] [Related]
3. Effects of an aqueous-ethanolic extract of ginger on cytochrome P450 enzyme-mediated drug metabolism.
Kim IS; Kim SY; Yoo HH
Pharmazie; 2012 Dec; 67(12):1007-9. PubMed ID: 23346764
[TBL] [Abstract][Full Text] [Related]
4. The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity.
Wang Z; Gorski JC; Hamman MA; Huang SM; Lesko LJ; Hall SD
Clin Pharmacol Ther; 2001 Oct; 70(4):317-26. PubMed ID: 11673747
[TBL] [Abstract][Full Text] [Related]
5. A new metabolite of irinotecan in which formation is mediated by human hepatic cytochrome P-450 3A4.
Sai K; Kaniwa N; Ozawa S; Sawada JI
Drug Metab Dispos; 2001 Nov; 29(11):1505-13. PubMed ID: 11602529
[TBL] [Abstract][Full Text] [Related]
6. A mechanistic study on altered pharmacokinetics of irinotecan by St. John's wort.
Hu ZP; Yang XX; Chen X; Cao J; Chan E; Duan W; Huang M; Yu XQ; Wen JY; Zhou SF
Curr Drug Metab; 2007 Feb; 8(2):157-71. PubMed ID: 17305494
[TBL] [Abstract][Full Text] [Related]
7. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.
Markowitz JS; Donovan JL; DeVane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
JAMA; 2003 Sep; 290(11):1500-4. PubMed ID: 13129991
[TBL] [Abstract][Full Text] [Related]
8. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole.
Wang LS; Zhou G; Zhu B; Wu J; Wang JG; Abd El-Aty AM; Li T; Liu J; Yang TL; Wang D; Zhong XY; Zhou HH
Clin Pharmacol Ther; 2004 Mar; 75(3):191-7. PubMed ID: 15001970
[TBL] [Abstract][Full Text] [Related]
9. Benefit-risk profile of black cohosh (isopropanolic
Ruan X; Mueck AO; Beer AM; Naser B; Pickartz S
Climacteric; 2019 Aug; 22(4):339-347. PubMed ID: 30626212
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
Obach RS
J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
[TBL] [Abstract][Full Text] [Related]
11. Biosynthesis of an aminopiperidino metabolite of irinotecan [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecine] by human hepatic microsomes.
Haaz MC; Riché C; Rivory LP; Robert J
Drug Metab Dispos; 1998 Aug; 26(8):769-74. PubMed ID: 9698291
[TBL] [Abstract][Full Text] [Related]
12. St John's Wort: effect on CYP3A4 activity.
Roby CA; Anderson GD; Kantor E; Dryer DA; Burstein AH
Clin Pharmacol Ther; 2000 May; 67(5):451-7. PubMed ID: 10824623
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic interactions of drugs with St John's wort.
Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
[TBL] [Abstract][Full Text] [Related]
14. The effect of St John's wort (hypericum perforatum) on cytochrome p450 1a2 activity in perfused rat liver.
Dostalek M; Pistovcakova J; Jurica J; Sulcova A; Tomandl J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):253-7. PubMed ID: 22286810
[TBL] [Abstract][Full Text] [Related]
15. Drug interactions with St John's wort : mechanisms and clinical implications.
Mannel M
Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
[TBL] [Abstract][Full Text] [Related]
16. Effect of St John's wort (Hypericum perforatum) on cytochrome P-450 activity in perfused rat liver.
Dostalek M; Pistovcakova J; Jurica J; Tomandl J; Linhart I; Sulcová A; Hadasova E
Life Sci; 2005 Dec; 78(3):239-44. PubMed ID: 16125735
[TBL] [Abstract][Full Text] [Related]
17. Drug interaction between St. John's wort and cyclosporine.
Barone GW; Gurley BJ; Ketel BL; Lightfoot ML; Abul-Ezz SR
Ann Pharmacother; 2000 Sep; 34(9):1013-6. PubMed ID: 10981246
[TBL] [Abstract][Full Text] [Related]
18. Application of Cryopreserved Human Intestinal Mucosa and Cryopreserved Human Enterocytes in the Evaluation of Herb-Drug Interactions: Evaluation of CYP3A Inhibitory Potential of Grapefruit Juice and Commercial Formulations of Twenty-Nine Herbal Supplements.
Loretz C; Ho MD; Alam N; Mitchell W; Li AP
Drug Metab Dispos; 2020 Oct; 48(10):1084-1091. PubMed ID: 32719085
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of irinotecan (CPT-11) by human hepatic microsomes: participation of cytochrome P-450 3A and drug interactions.
Haaz MC; Rivory L; Riché C; Vernillet L; Robert J
Cancer Res; 1998 Feb; 58(3):468-72. PubMed ID: 9458091
[TBL] [Abstract][Full Text] [Related]
20. Effect of St John's wort on imatinib mesylate pharmacokinetics.
Frye RF; Fitzgerald SM; Lagattuta TF; Hruska MW; Egorin MJ
Clin Pharmacol Ther; 2004 Oct; 76(4):323-9. PubMed ID: 15470331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
